Skip to content
2000
Volume 23, Issue 10
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The application of privileged structures in drug design is an effective strategy, which usually leads to innovative hits/leads and successful structural optimization. Pyrrolo[2, 3- d]pyrimidine are such a scaffold which are frequently used in many clinical drugs. The biocompounds bearing pyrrolo[2, 3-d]pyrimidine skeleton show different pharmacological effects such as anti-neurodegenerative, anti-inflammatory, antibacterial, and antitumor activities. In this article, we reviewed the representative structures and biological characteristics of reported synthetic pyrrolo[2, 3-d]pyrimidine compounds from 2017 to 2021. The linked diseases and targets were also mentioned briefly. This work might provide a reference for the subsequent drug discovery based on pyrrolo[2, 3-d]pyrimidine scaffold.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557523666230111161810
2023-06-01
2025-08-19
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557523666230111161810
Loading

  • Article Type:
    Review Article
Keyword(s): 3-d]pyrimidine; anti-inflammatory; antibacterial; antitumor activities; IKKs; NIK; Pyrrolo[2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test